RecruitingPhase 2NCT03841617
Endocrine
Differentiated thyroid carcinoma
37
studies recruiting now
as of 7 Sept 2026
240
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
20 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT07777536
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer
RecruitingPhase 3NCT06475989
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
RecruitingPhase 2NCT03099356
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
RecruitingNCT05575440
Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 37 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Differentiated thyroid carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Differentiated thyroid carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (BRAF, EIF1AX, PPARG, RET, KRAS, CCDC6).
Treatments being studied
3 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Levothyroxine Sodium (Eltroxin)Approved: Lenvatinib (Kisplyx)Approved: Liothyronine Sodium (Cynomel)
Phase 2Cisplatin (Cisplatin)
Phase 2Rivoceranib Mesylate (Aitan)
Phase 2Doxorubicin Hydrochloride (Adriamycin)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).